Abvc Biopharma, Inc.
ABVC· Nasdaq
Abvc Biopharma, Inc.
- Last sale
- Oct 2, 2026 · -1.46%
- Market cap
- $26.92M
- 26.65M shares
- Filings
- 794
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $296,000 | reported | |
| FY 2024 | 2024-12-31 | $509,589 revised | reported | |
| FY 2023 | 2023-12-31 | $152,430 | reported | |
| FY 2022 | 2022-12-31 | $969,783 | reported | |
| FY 2021 | 2021-12-31 | $355,797 | reported | |
| FY 2020 | 2020-12-31 | $483,045 | reported | |
| FY 2019 | 2019-12-31 | $701,719 | reported | |
| FY 2018 | 2018-12-31 | $6,956 | reported | |
| FY 2015 | 2015-12-31 | $50,000,000 | reported | |
| FY 2014 | 2014-09-18 | $0 | reported | |
| FY 2013 | 2013-09-30 | $7,787 | reported |
Abvc Biopharma, Inc. · CIK 1173313 · Engraved from SEC EDGAR
